Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fetzima in Geriatric Depression
NCT02466958Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levomilnacipran in major depressive disorder (MDD), sponsored by University of California, Los Angeles. Started Jun 2016; status: completed.
02
Drugs
levomilnacipran
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02466958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02466958.